InvestSMART

BTC Health Ltd (ASX:BTC)

ALERT: Price-sensitive ASX Announcement for BTC
Current share price for BTC : $0.057 -0.003 (-5%)+
Announcement
Release
20 Aug 2026 7:18PM
Price at Release
$0.060
Full Release
download
Summary
BTC Health Ltd announced its financial results for FY2026, highlighting a year of consolidation with positive EBITDA of $0.14 million, an increase in cardio product revenue by 31%, and the maintenance of a steady group revenue of $10.3 million. Although the company did not meet its double-digit growth targets due to purchase order timing in the public hospital system affecting ECMO revenue, it made significant strategic advancements. The cardio franchise now represents 57% of group revenue, and the company secured new distribution agreements to expand its cardiac and critical care portfolio. The adjusted EBITDA saw a 49% increase to $0.27 million, and total cash reserves improved to $2.1 million. BTC Health also focused on transitioning infusion pump users to new devices and plans to further capitalize on its ECMO pipeline and distribution agreements in FY2027.
Key Points
  • BTC Health Ltd reported FY2026 financial results.
  • Positive EBITDA of $0.14 million achieved.
  • 31% increase in cardio product revenue.
  • Group revenue remained steady at $10.3 million.
  • Cardio products now account for 57% of revenue.
  • Adjusted EBITDA increased by 49% to $0.27 million.
  • New distribution agreements were secured.
  • Total cash reserves rose to $2.1 million.
  • Focus on converting ECMO pipeline in FY2027.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.